204 related articles for article (PubMed ID: 29516965)
1. Preablation neutrophil-to-lymphocyte ratio as an independent prognostic factor in locally advanced hepatocellular carcinoma patients following radiofrequency ablation.
Tan W; Sun W; Li X; Zhao L; Wang C; Zang A; Kong X
J Cancer Res Ther; 2018 Jan; 14(1):84-89. PubMed ID: 29516965
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
[TBL] [Abstract][Full Text] [Related]
3. Using Pre-Treatment Neutrophil-to-Lymphocyte Ratio to Predict the Prognosis of Young Patients with Hepatocellular Carcinoma Implemented Minimally Invasive Treatment.
Sun S; Wang X; Chen J
J Adolesc Young Adult Oncol; 2020 Feb; 9(1):85-89. PubMed ID: 31621472
[No Abstract] [Full Text] [Related]
4. Postoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation.
Dan J; Zhang Y; Peng Z; Huang J; Gao H; Xu L; Chen M
PLoS One; 2013; 8(3):e58184. PubMed ID: 23516447
[TBL] [Abstract][Full Text] [Related]
5. [Correlation between postoperative neutrophil to lymphocyte ratio and recurrence and prognosis of hepatocellular carcinoma after radical liver resection].
Wu XL; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):365-371. PubMed ID: 29860764
[No Abstract] [Full Text] [Related]
6. Prognostic significance of the CRP/Alb and neutrophil to lymphocyte ratios in hepatocellular carcinoma patients undergoing TACE and RFA.
Shen Y; Wang H; Li W; Chen J
J Clin Lab Anal; 2019 Nov; 33(9):e22999. PubMed ID: 31418936
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil-to-lymphocyte ratio predicts recurrence after radiofrequency ablation in hepatitis B virus infection.
Tajiri K; Baba H; Kawai K; Minemura M; Yasumura S; Takahara T; Sugiyama T
J Gastroenterol Hepatol; 2016 Jul; 31(7):1291-9. PubMed ID: 26729319
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation.
Chen TM; Lin CC; Huang PT; Wen CF
J Gastroenterol Hepatol; 2012 Mar; 27(3):553-61. PubMed ID: 21913982
[TBL] [Abstract][Full Text] [Related]
9. A combination of the preoperative neutrophil-to-lymphocyte and lymphocyte-to-monocyte ratios as a useful predictor of survival outcomes following the transarterial chemoembolization of huge hepatocellular carcinoma.
Liu J; Zhang W; Niu R; Li Y; Zhou X; Han X
Saudi Med J; 2020 Apr; 41(4):376-382. PubMed ID: 32291424
[TBL] [Abstract][Full Text] [Related]
10. The Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Patients with Unresectable Hepatocellular Carcinoma Treated with Radioembolization.
Sukato DC; Tohme S; Chalhoub D; Han K; Zajko A; Amesur N; Orons P; Marsh JW; Geller DA; Tsung A
J Vasc Interv Radiol; 2015 Jun; 26(6):816-24.e1. PubMed ID: 25824315
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment Inflammation-Based Markers Predict Survival Outcomes in Patients with Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation.
Chu MO; Shen CH; Chang TS; Xu HW; Yen CW; Lu SN; Hung CH
Sci Rep; 2018 Nov; 8(1):16611. PubMed ID: 30413724
[TBL] [Abstract][Full Text] [Related]
12. Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma.
Takada H; Tsuchiya K; Yasui Y; Nakakuki N; Tamaki N; Suzuki S; Nakanishi H; Itakura J; Takahashi Y; Kurosaki M; Asahina Y; Enomoto N; Izumi N
Cancer Med; 2016 Nov; 5(11):3111-3120. PubMed ID: 27748052
[TBL] [Abstract][Full Text] [Related]
13. Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma.
Xiao GQ; Yang JY; Yan LN
Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):588-95. PubMed ID: 26663006
[TBL] [Abstract][Full Text] [Related]
14. A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI).
Ji F; Liang Y; Fu SJ; Guo ZY; Shu M; Shen SL; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2016 Feb; 16():137. PubMed ID: 26907597
[TBL] [Abstract][Full Text] [Related]
15. Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization.
Zhou DS; Xu L; Luo YL; He FY; Huang JT; Zhang YJ; Chen MS
World J Gastroenterol; 2015 May; 21(18):5582-90. PubMed ID: 25987783
[TBL] [Abstract][Full Text] [Related]
16. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.
He CB; Lin XJ
PLoS One; 2017; 12(3):e0174769. PubMed ID: 28355305
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil-to-lymphocyte and aspartate-to-alanine aminotransferase ratios predict hepatocellular carcinoma prognosis after transarterial embolization.
Liu C; Jia BS; Zou BW; Du H; Yan LN; Yang JY; Jiang L; Wen TF; Lu WS
Medicine (Baltimore); 2017 Nov; 96(45):e8512. PubMed ID: 29137051
[TBL] [Abstract][Full Text] [Related]
18. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥10 cm) hepatocellular carcinoma.
Goh BK; Kam JH; Lee SY; Chan CY; Allen JC; Jeyaraj P; Cheow PC; Chow PK; Ooi LL; Chung AY
J Surg Oncol; 2016 May; 113(6):621-7. PubMed ID: 26861568
[TBL] [Abstract][Full Text] [Related]
19. An elevated neutrophil-to-lymphocyte ratio predicts a poor postoperative survival in primary hepatocellular carcinoma patients with a normal preoperative serum level of alpha-fetoprotein.
Shiraki T; Ishizuka M; Kubota K; Kato M; Matsumoto T; Mori S; Shimizu T; Aoki T
Surg Today; 2019 Aug; 49(8):661-669. PubMed ID: 30806789
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies.
Bruix J; Cheng AL; Meinhardt G; Nakajima K; De Sanctis Y; Llovet J
J Hepatol; 2017 Nov; 67(5):999-1008. PubMed ID: 28687477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
